Volm M, Mattern J, Müller T, Drings P
German Cancer Research Center, Institute of Experimental Pathology, Heidelberg, F.R.G.
Anticancer Res. 1988 Jan-Feb;8(1):105-12.
Surgical specimens of tumors of 105 patients with previously untreated epidermoid lung carcinomas were investigated by means of flow cytometry and the results compared with the survival of the patients. The aim of the present prospective study was to establish further the efficacy of cytometric analysis, independent of well known clinical factors. For determining prognosis, all patients had a minimum of 5 years follow-up. The present study clearly shows that, independent of clinical characteristics, cytometric DNA content analysis has prognostic importance in patients with epidermoid lung carcinomas. Patients with aneuploid tumors died significantly sooner than those who had tumors with DNA diploidy. Patients whose tumors had a high proliferative activity (proportion of Go/G1-phase-cells less than or equal to 78%, S-phase-cells greater than 8%, G2M-phase-cells greater than 14%) died significantly earlier than patients with tumors with lower proliferation activity. Comparisons within homogeneous groups of patients with respect to the clinical characteristics (T3, NM+, stage III, surgery, treatment) showed identical results. In addition to the univariate analyses, multivariate analyses (Cox-regression model) were used. The results of this study demonstrate two groups of independent prognostic factors for the survival of patients with epidermoid carcinomas: clinical factors and flow cytometric factors.
对105例未经治疗的肺表皮样癌患者的肿瘤手术标本进行了流式细胞术研究,并将结果与患者的生存率进行了比较。本前瞻性研究的目的是进一步确定细胞计量分析的有效性,而不考虑众所周知的临床因素。为了确定预后,所有患者至少随访5年。本研究清楚地表明,不考虑临床特征,细胞计量DNA含量分析对肺表皮样癌患者具有预后重要性。非整倍体肿瘤患者的死亡时间明显早于DNA二倍体肿瘤患者。肿瘤具有高增殖活性(G0/G1期细胞比例小于或等于78%,S期细胞大于8%,G2M期细胞大于14%)的患者比增殖活性较低的肿瘤患者死亡时间明显更早。在临床特征(T3、NM+、III期、手术、治疗)方面对同质患者组进行的比较显示了相同的结果。除单变量分析外,还使用了多变量分析(Cox回归模型)。本研究结果表明,肺表皮样癌患者生存的两组独立预后因素为:临床因素和流式细胞术因素。